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Nevertheless, despite these limitations, it is suggested that useful new information has been obtained on the native Fc sites involved in three different types of effector functions: auto-antigenicity, cytophilicity and target-cell signalling.
It will now be important to extend this approach to confirm that the activities attributed to the different synthetic peptides examined are indeed specific, rather than due to non-specific effects which can confuse the interpretation of data obtained from such studies.
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The relationship between the immune system and mucus in the protection of mucous membranes JOHN R. CLAMP Department of Medicine, University of Bristol. Bristol Royal Injrmary, Bristol BS2 8HW, U.K.
Mucus is a complex secretion that covers and protects most of the internal epithelial surfaces of the body. It appeared early in evolution, similar material having been found for example in earthworm and snail (J. R. Clamp, unpublished work) . The component that confers on mucus its viscous, slimy and sticky properties is a high molecular weight glycoprotein. This glycoprotein has a characteristic carbohydrate and amino acid content and consists of a long polypeptide chain to which are attached many hundreds if not thousands of relatively small oligosaccharide units. The glycoprotein determines the nature of the mucus gel, but in addition a number of other components are added to mucus which enhance its protective properties. The non-immune protective functions of mucus secretions have been largely ignored. The majority of infections, whether viral or bacterial, gain access to the body through the mucous membranes. When man meets a potential pathogen for the first time he is in a similar position to an animal with a primitive immune system. Yet both man and earthworm survive in a hostile world, and that they do depends to a large extent on their mucus secretions. The evolution of a sophisticated immune system complemented, and interacted with, but did not replace the protective functions of mucus secretions. Indeed in man, chronic disturbance of Abbreviation used: Ig, immunoglobulin.
mucociliary clearance is more likely to lead to respiratory infection than IgA deficiency. The mucus gel layer may play non-specific and specific roles in the protection of the underlying membrane. It is possible that mucus acts as an exclusion barrier to dissimilar macromolecules such as antigens or toxins (Edwards, 1978) .
There is no direct evidence for this idea, but in keeping with it is the fact that the antigen-processing lymphoid tissue in Peyer's patches is covered by modified epithelium devoid of mucus-secreting cells or indeed of glycocalyx. The physical nature of mucus, that is its general 'stickiness', makes it ideal for trapping micro-organisms. However, more important are the specific interactions between mucus glycoprotein and toxins, viruses and bacteria. Infection is usually initiated by adherence of the micro-organism to carbohydrate structures at the cell surface. This has been shown with a range of bacteria (Anderson et al., 1983; Parkkinen et al., 1983) and viruses (Carroll et al., 1981) . The oligosaccharide units in mucus glycoproteins share similar carbohydrate sequences to the glycoconjugates at cell surfaces. This was recognized early, for example in the work on ABO blood group antigens. These carbohydrate antigens are present in the glycolipids of many cells including epithelial cells and are also present in the mucus secretions of the majority of the population ('secretors'). The spurious attachment sites in mucus may act by competing with the genuine sites at the mucosal cell surface. In addition specific affinities between micro-organisms and mucus will retain the pathogen within the mucus layer and retard its progress through the layer to reach the mucosal cells. Interaction be-607th MEETING, LONDON tween viruses and mucus was shown over 30 years ago (Burnet, 1951) and similar interactions have been demonstrated with cholera toxin (Strombeck & Harrold, 1974 ) and a range of bacteria such as streptococci (Williams & Gibbons, 1975; Levine et al., 1982) and pseudomonas (Ramphal & Pyle, 1983) . Micro-organisms will also stimulate the release of mucus from intestinal goblet cells. This can be a direct effect of toxins (Moon et al., 1971 ; Sherr et al., 1979; Adler et al., 1981) or be mediated by antigen (Lake et al., 1979) through the immune system as immune complexes (Walker et al., 1977) or by IgE release in the submucosa (Lake et al., 1980) .
The role of mucus in the expulsion of intestinal parasites is well documented, probably because the process can be followed macroscopically. Thus in rats previously exposed to the parasite, the intestinal mucus layer was an effective barrier to larvae of Trichinella spiralis (Lee & Ogilvie, 1982) . Mucus also appears to be an important component in the rapid expulsion of Nippostrongylus brasiliensis from the intestines of immune rats (Miller et al., 1981) for it was observed that during expulsion the worms were engulfed in copious amounts of thick mucus. It is tempting to believe that in these cases resistance to the parasites involved interaction between mucus and the immune system.
Trapping of toxins or micro-organisms in the mucus layer would be of little benefit in the protection of mucosal surfaces unless the mucus secretions were being continually removed and replaced by fresh secretions. This is carried out very effectively. In the body, all actual or potential 'blind alleys', such as lungs or sinuses, are lined with ciliated epithelium. The mucus layer, together with any trapped particles, are moved along by the co-ordinated ciliary beat so that the half-life of the mucus layer in normal lung, for example, is only 2-3h ( Thompson & Short, 1969) . The effectiveness of mucociliary clearance is dependent upon the rheological properties of the mucus (King et al., 1974) in that a gel-like structure is essential. The study was carried out on frog palate and it was found that the moving mucus layer was able to transport relatively large and heavy objects against gravity, indicating the efficiency of the system in clearing the lungs of inhaled particles.
In the gastrointestinal tract the clearance of mucus is by a different mechanism. The mucus gel layer is constantly renewed from below and is lost at the surface, possibly by proteolysis. Almost any proteolytic enzyme is effective in destroying the gel structure of mucus by cleaving the glycoprotein molecule in the 'naked peptide' region (Clamp et al., 1978) . The resultant glycopolypeptides have reduced viscous properties, are extremely soluble and pass out into the lumen to be swept on by the peristaltic movements of the intestine. As in lungs, clearance is all-important and it has been shown that peristalsis alone is the most important factor in clearing bacteria from the small intestine (Dixon, 1960) . It is not surprising therefore that the body has developed the almost invariable response of diarrhoea and/or vomiting to gastrointestinal infections, presumably to enhance the normal clearance mechanism.
A number of components are added to mucus secretions to increase protection of the mucosa. Alexander Fleming (1922) observed that most body secretions contained a 'ferment' that was able to lyse certain bacteria, principally streptococci and staphylococci. The ferment (enzyme) he called lysozyme. The enzyme is a muramidase, that is it cleaves the link between muramic acid and N-acetylglucosamine in the peptidoglycan component of certain bacterial cell walls. As with many components of mucus there is interaction between lysozyme and the mucus glycoprotein (Creeth et al., 1979) . Presumably this is to retain the enzyme within the mucus gel structure and to augment the antibacterial properties of the secretion.
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Lactoferrin is also a component of mucosal secretions. This protein has a high affinity for iron and is believed to achieve its bacteriostatic effect by depriving bacteria of iron as an essential growth requirement (Bullen et al., 1972; Emery, 1980) . Surprisingly the gut is also believed to be an important excretory organ in iron homoeostasis not only by loss of iron-containing epithelial cells but also by the presence of iron in mucus-secreting goblet cells (Refsum & Schreiner, 1980) . The role of iron in secretions is also complicated by its powerful catalytic effect in producing hydroxy radicals from 'superoxide'. There is therefore a complex relationship between iron absorption, iron excretion, lactoferrin and the role of iron in oxygen-dependent killing of micro-organisms by phagocytes in secretions. Interestingly the neutrophils themselves contain large amounts of lactoferrin (Murphy, 1976; Root & Cohen, 1981) , though whether this is as an iron source or to prevent accumulation of free iron is not clear. Certainly the view that the primary role of transferrin is to deprive bacteria of iron is much too simplistic. As with other components of secretions, there is interaction between mucus and leucocytes. Possibly mucus affects macrophage function directly (Woodside et al., 1983) . Conversely leucocytes have an effect upon mucus through the production of oxygen radicals. Creeth et al. (1983) studied the effect of hydrogen peroxide on mucus glycoprotein. In the presence of iron or copper, the glycoprotein was rapidly cleaved at histidine residues producing a considerable drop in the molecular weight. In the body this would have the effect of destroying the mucus gel structure so that the various oxygen species are acting as true mucolytics. Thus the liquefied mucus together with the micro-organisms that triggered the reaction can be rapidly cleared from the body.
Apart from lysozyme and lactoferrin, there may be other factors in secretions that have a protective role. For example high titres of interferon are found in intestines during viral enteritis (La Bonnardiere & Laude, 1981) . In addition studies on mice incapable of significant antibody production, showed that they had a normal pattern of worm expulsion (Jacobson et al., 1977) . Wakelin (1978) commenting on these findings wondered if humoral factors other than antibodies were involved in the first step of worm explusion.
IgA is also present in mucosal secretions, with both subclasses, namely IgAl and IgA2, being represented. Early work on the carbohydrate of IgA was carried out on myeloma (monomeric) immunoglobulins (Dawson & Clamp, 1967 , 1968 . It was shown that IgAl possesses a number of disaccharide units that are 0-glycosidically linked in the hinge region. This region together with the disaccharide units is deleted in IgA2. Of greater interest is the fact that in SIgAl the disaccharide units have been built up into units closely resembling those present in mucus glycoprotein (J. R. Clamp & F. J. Bourne, unpublished work) . Thus the disaccharide unit contains only galactose joined to the linkage N-acetylgalactosamine, whereas in SIgA the units contain additional galactose as well as fucose and N-acetylglucosamine. Unfortunately the carbohydrate of dimeric IgA is not known, but the only possibilities are either that plamsa cells committed to dimeric IgA production synthesize larger 0-linked units or that the units are enlarged during passage through the mucosa. Whichever possibility turns out to be correct may have important implications for the process of committing antibodies to mucosal secretions.
The presence of a 'mucus-like' stretch in SIgA1, that is a stretch similar in amino acid and carbohydrate composition to mucus glycoprotein, has led to speculation about its function (Clamp, 1977) . The idea that the stretch enables SIgAl to interact with or be associated with the mucus gel
